期刊文献+

诺如病毒病毒样颗粒的表达及其与HBGAs受体的结合研究 被引量:5

Expression of GⅡ-4 strain NoV virus-like particles and analysis of its binding activity with HBGAs receptor
下载PDF
导出
摘要 目的:以杆状病毒为载体,在昆虫细胞sf9中表达GⅡ-4型野生株诺如病毒(Noroviruses,NoV)GZ121的衣壳蛋白ORF2,并验证其与组织血型抗原(Histoblood group antigen,HBGAs)受体的结合活性。方法:双酶切质粒PMD18-T-GZ121 ORF2酶切,连接入线性化载体PFastBacTM1,获得重组转座载体pFastBac-GZ121 ORF2,利用Bac-to-Bac杆状病毒表达系统获得重组杆状病毒,将其转染昆虫sf9细胞进行蛋白表达,用蔗糖超离方法纯化以及免疫印迹、透射电镜等方法鉴定表达产物,用EIA法检测NoV-VLP与HBGAs的结合特性。结果:成功表达了分子量约为58 kD的NoV衣壳蛋白,大小约30 nm与预期相符,NoV-VLP与A、B、O型均能结合,与非分泌型唾液不结合,结合方式与rVA387相一致。结论:我国优势流行株GⅡ4型NoV病毒样颗粒(Virus-like particles,VLP)的表达成功及NoV-VLP和HBGAs受体结合模型的建立,为我国NoV疫苗的开发和防治药物的研究奠定了基础。 Objective: To express the capsids of the predominant strain NoV(GⅡ-4) of our country and explore its binding activity and pattern model with HBGAs receptor.Methods: GZ121 NoV ORF2 gene was constructed into baculovirus expression system.After the transfection to sf9 cells,the recombinant proteins were purified by sucrose ultra centrifugation,and then were identified by SDS PAGE,Western blot and TEM.And the binding patterns of NoV to HBGAs antigens were identified by EIA.Results: VLPs expression was confirmed by using SDS PAGE,Western blot and could bind to all secretors(OD2.5),but not to all nonsecretors(OD≈0.3).Conclusion: The GⅡ-4 NoV VLP was successfully expressed and HBGAs receptor binding assays were established.These data will help us to explore the host adaptation character of NoV and apply the assays to screen drugs for antivirals against Noroviruses.The results obtained in the present work will also lay a foundation for the development of the immunological diagnostic reagents as well as vaccines for Norovirus.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2011年第3期315-318,共4页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(编号:30700716、30901992)
关键词 诺如病毒 杆状病毒表达系统 病毒样颗粒 HBGAs受体 norovirus baculovirus expression vector system virus like particles HBGAs receptor
  • 相关文献

参考文献13

  • 1Cremon C,de Giorgio R,Barbara G.Norovirus gastroenteritis [J].N Engl J Med, 2010,362 (6) : 557,557-558.
  • 2Patel M M,Widdowson M A,Glass R I,et al. Systematic literature review of role of noroviruses in sporadic gastroenteritis[J].Emerg Infect Dis, 2008,14(8) : 1224-1231.
  • 3Dai Y C, Xia M, Zhan H C, et al. Surveillance and risk factors of norovirus gastroenteritis among children in a southern city of China in the fall-winter seasons of 2003-2006[J].J Paediatr Child Health, 2009,46 ( 1-2 ) : 45-50.
  • 4Jiang X, Wang M,Graham D Y,et al. Expression, self-assembly, and antigenieity of the Norwalk virus capsid protein[J].J Virol, 1992,66( 11 ) : 6527-6532.
  • 5张绪富,戴迎春,周迎春,吕志平.GII-4型诺如病毒ORF2基因克隆及序列分析[J].中国公共卫生,2010,26(2):194-196. 被引量:3
  • 6Jiang X,Wilton N,Zhong W M,Farkas T,et al.Diagnosis of human caliciviruses by use of enzyme immunoassays[J].J Infect Dis, 2000,181 (2s) : 349-359.
  • 7Huang P, Farkas T,Zhong W, et al. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns [J]. J Virol,2005, 79( 11 ) :6714-6722.
  • 8张绪富,戴迎春,夏仁飞,周迎春,吕志平.GⅡ-4型诺如病毒体外结合唾液HBGAs受体的检测与分析[J].中国人兽共患病学报,2009,25(6):560-562. 被引量:8
  • 9Harrington P R, Yount B, Johnston R E,et al. Systemic,mueosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles [J].J Virel, 2002,76(2 ) : 730-742.
  • 10Herbst-Kralovetz M,Mason H S,Chen Q.Norwalk virus-like particles as vaccines[J]. Expert Rev Vaccines, 2010,9 (3) : 299-307.

二级参考文献44

  • 1Goodgame R. Norovirus gastroenteritis [ J ]. Curr Gastroenterol Rep, 2006, 8(5):401 -8.
  • 2Iijima Y, Tanaka S, Ohishi H. Multiple outbreaks of gastroenteritis due toa single strain of genotype GII/4 norovirus in Kobe, Japan, 2006: risk factors for norovirus spreasd in health care settings. Jpn J Infect Dis ,2008,61 (5) :419 - 22.
  • 3Fankhauser R L, Monroe S S, Noel J S, et al. Epidemiologic and molecular trends of " Norwalk-like viruses" associated with outbreaks of gastroenteritis in the United States [ J ]. J Infect Dis, 2002, 186(1) :1 -7.
  • 4Dai Y C, Nie J, Zhang X F, et al. Seroprevatence of antibodies against noroviruses among students in a Chinese military medical university [ J ]. J Clin Microbio , 2004,42 (10) :4615 - 9.
  • 5Hardy M E. Norovirus protein structure and function [ J ]. FEMS Microbiol Lett, 2005, 253 ( 1 ) : 1 - 8.
  • 6Ho D D. How far can you knock down HIV? An interview with David D. Ho, MD. Interview by Mark Mascolini[J]. J lnt Assoc Physicians AIDS Care, 1997, 3(6) :40 -4.
  • 7Chan M, Wong Y, Sung J, Leung W. Ex vivo support and suppression of human norovirus RNA replication [ J ]. International Calicivirus Conference, 2007, 3 : Aba S6 - 8.
  • 8Katz B A, Clark J M, Finer-Moore J S, et .al. Design of potent selective zinc-mediated serine protease inhibitors [ J ]. Nature, 1998, 5;391(7) :608 -12.
  • 9Zeitler C E, Estes M K, Venkataram Prasad B V. X-ray crystallographic structure of the Norwalk virus protease at 1.5-A resolution [J]. J Virol, 2006, 80(10) :5050 - 8.
  • 10O'Reilly E K, Kao C C. Analysis of RNA-dependent RNA polymerase structure and function as guided by known polymerase structures and computer predictions of secondary structure [ J ]. Virolog, 1998, 252(2) :287 -303.

共引文献9

同被引文献67

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部